DANTROLENE
Ryanodex approved at February 2017 P&T Committee meeting for initial dosing to treat malignant hyperthermia (MH).
Ryanodex approved at February 2017 P&T Committee meeting for initial dosing to treat malignant hyperthermia (MH).